A new strain of gonorrhea has emerged, causing significant concern among health professionals due to its resistance to traditional treatments. This sexually ...
Metro Detroit has earned the dubious distinction of leading the country with the highest rate of sexually transmitted ...
Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical ...
The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...
Understanding ovarian cancer's early warning signs has long challenged medical professionals, making risk factor awareness ...
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...
Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.
Officials at the local department of health raised the alarm in a health alert, saying the patients had taken ceftriaxone, or ...
Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple ...
Roche AG secured U.S. FDA 510(k) clearance for its cobas liat sexually transmitted infection (STI) multiplex assay panels. The tests, which also received a Clinical Laboratory Improvement Amendments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback